---
category: news
title: "Trial backs Lillyâ€™s Olumiant plus remdesivir as combo COVID-19 therapy"
excerpt: "Eli Lilly says rheumatoid arthritis drug Olumiant helps speed COVID-19 recovery when added to Gilead's remdesivir by around 1 day. Will discuss emergency use with FDA"
publishedDateTime: 2020-09-16T08:46:00Z
originalUrl: "https://pharmaphorum.com/news/trial-backs-lillys-olumiant-plus-remdesivir-as-combo-covid-19-therapy/"
webUrl: "https://pharmaphorum.com/news/trial-backs-lillys-olumiant-plus-remdesivir-as-combo-covid-19-therapy/"
type: article

provider:
  name: pharmaphorum.com
  domain: pharmaphorum.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pharmaphorum.com/wp-content/uploads/2016/06/LillYLOGO.jpg"
    width: 1800
    height: 987
    isCached: true

secured: "bcNpf5Orx3IWuxnz2nJaeER9K4mFqVZWInMhvJugn4KmE/DTH08pfHseXYrYrFni/shqG478fFX6lzQt/7FSzjMqeoBQrcIR62hhGroiN093b6H8ePuS/gVATOc/M+n93YvoVib8pjqj8f1pIoWHsDb0AWclVxzNW4d4E88GQ4+5Z+Cxs+jMBEygkOgKnq6btz8AH2ugUx/0mDEWNAxSeiSXMyy8hHLKSCH1+/Ngp2zTnTv6WnKO3y20hv0FgSsHqq5ssELNsG7IOiFxBW2a8DACAEzAaoLU05kQ7/A6fhTpDCOjj+7XBvb/cqAoTQlapcfrhwMI3MB6KLC0O/HM+etgMWdlvj8LQSREB33UvNQ=;xvNyZCFs8lR7wNCMXl5a9Q=="
---

